PALLADINI, GIOVANNI
PALLADINI, GIOVANNI
DIPARTIMENTO DI MEDICINA MOLECOLARE
4D flow evaluation of blood non-Newtonian behavior in left ventricle flow analysis
2021-01-01 Riva, A.; Sturla, F.; Caimi, A.; Pica, S.; Giese, D.; Milani, P.; Palladini, G.; Lombardi, M.; Redaelli, A.; Votta, E.
A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis
2014-01-01 L., Diomede; P., Rognoni; Lavatelli, Francesca; M., Romeo; E. d., Favero; L., Cantù; E., Ghibaudi; A. d., Fonzo; A., Corbelli; F., Fiordaliso; Palladini, Giovanni; V., Valentini; V., Perfetti; M., Salmona; Merlini, Giampaolo
A case of monoclonal gammopathy of renal significance
2020-01-01 Ripepi, J.; Basset, M.; Bozzola, M.; Milani, P.; Nuvolone, M.; Lavatelli, F.; Ferraro, G.; Bosoni, T.; Pirolini, L.; Albertini, R.; Palladini, G.
A complicated evaluation of the response to the therapy in a patient with light chain deposition disease
2020-01-01 Ripepi, J.; Basset, M.; Milani, P.; Nuvolone, M.; Foli, A.; Bozzola, M.; Bosoni, T.; Albertini, R.; Palladini, G.
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis
2015-01-01 Palladini, Giovanni; Sachchithanantham, S.; Milani, Paolo; Gillmore, J.; Foli, Andrea; Lachmann, H.; Basset, Marco; Hawkins, P.; Merlini, Giampaolo; Wechalekar, A. D.
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.
2013-01-01 Wechalekar, A. D.; Schonland, S. O.; Kastritis, E.; Gillmore, J. D.; Dimopoulos, M. A.; Lane, T.; Foli, A.; Foard, D.; Milani, P.; Rannigan, L.; Hegenbart, U.; Hawkins, P. N.; Merlini, Giampaolo; Palladini, Giovanni
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis.
2001-01-01 Palladini, Giovanni; Anesi, E; Perfetti, V; Obici, L; Invernizzi, Rosangela; Balduini, Carlo; Ascari, Edoardo; Merlini, Giampaolo
A modified high-dose dexamethasone regimen for primary systemic amyloidosis
1999-01-01 Merlini, Giampaolo; Anesi, E; Palladini, Giovanni; Perfetti, V; Obici, L; Invernizzi, Rosangela; Balduini, Carlo; Ascari, Edoardo; Cazzola, Mario
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin in primary amyloidosis (AL)
2002-01-01 Gertz, Ma; Lacy, Mq; Dispenzieri, A; Cheson, B; Barlogie, B; Kyle, Ra; Palladini, Giovanni; Geyer, S; Merlini, Giampaolo
A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis
2022-01-01 Palladini, G.; Celant, S.; Milani, P.; Summa, V.; Affronti, G.; Olimpieri, P. P.; Petraglia, S.; Foli, A.; Nuvolone, M.; Merlini, G.; Russo, P.
A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options
2019-01-01 Moutafi, M.; Ziogas, D. C.; Michopoulos, S.; Bagratuni, T.; Vasileiou, V.; Verga, L.; Merlini, G.; Palladini, G.; Matsouka, C.; Dimopoulos, M. A.; Kastritis, E.
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy
2005-01-01 Obici, L.; Demarchi, A.; de Rosa, G.; Bellotti, Vittorio; Marciano, S.; Donadei, S.; Arbustini, E.; Palladini, Giovanni; Diegoli, M.; Genovese, E.; Ferrari, G.; Coverlizza, S.; Merlini, Giampaolo
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy.
2005-01-01 Obici, L; Demarchi, A; DE ROSA, G; Bellotti, Vittorio; Marciano, S; Donadei, S; Arbustini, Eloisa; Palladini, Giovanni; Diegoli, M; Genovese, E; Ferrari, G; Coverlizza, S; Merlini, Giampaolo
A novel approach for the purification and proteomic analysis of pathogenic immunglobulin free light chains from serum
2011-01-01 Lavatelli, Francesca; Brambilla, Francesca; Valentini, Veronica; Rognoni, Paola; Casarini, Simona; Di Silvestre, Dario; Perfetti, Vittorio; Palladini, Giovanni; Sarais, Gabriele; Mauri, Pierluigi; Merlini, Giampaolo
A patient with AL amyloidosis with negative free light chain results
2016-01-01 Milani, Paolo; Valentini, Veronica; Ferraro, Giovanni; Basset, Marco; Russo, Francesca; Foli, Andrea; Palladini, Giovanni; Merlini, Giampaolo
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory light-chain (AL) amyloidosis
2017-01-01 Sanchorawala, V; Palladini, Giovanni; Kukreti, V; Zonder, Ja; Cohen, Ad; Seldin, Dc; Dispenzieri, A; Jaccard, A; Schönland, So; Berg, D; Yang, H; Gupta, N; Hui, Am; Comenzo, Rl; Merlini, Giampaolo
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis
2017-01-01 Palladini, G.; Milani, P.; Foli, A.; Basset, M.; Russo, F.; Perlini, S.; Merlini, G.
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis
2017-01-01 Palladini, Giovanni; Milani, Paolo; Foli, Andrea; Basset, Marco; Russo, Francesca; Perlini, Stefano; Merlini, Giampaolo
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis
2013-01-01 Palladini, Giovanni; Russo, PAOLA ROSA NICE MARIA; Milani, P.; Foli, A.; Lavatelli, Francesca; Nuvolone, MARIO ULISSE; Perlini, Stefano; Merlini, Giampaolo
A powerful oral triplet for AL amyloidosis
2020-01-01 Palladini, G.; Milani, P.; Merlini, G.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
4D flow evaluation of blood non-Newtonian behavior in left ventricle flow analysis | 1-gen-2021 | Riva, A.; Sturla, F.; Caimi, A.; Pica, S.; Giese, D.; Milani, P.; Palladini, G.; Lombardi, M.; Redaelli, A.; Votta, E. | |
A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis | 1-gen-2014 | L., Diomede; P., Rognoni; Lavatelli, Francesca; M., Romeo; E. d., Favero; L., Cantù; E., Ghibaudi; A. d., Fonzo; A., Corbelli; F., Fiordaliso; Palladini, Giovanni; V., Valentini; V., Perfetti; M., Salmona; Merlini, Giampaolo | |
A case of monoclonal gammopathy of renal significance | 1-gen-2020 | Ripepi, J.; Basset, M.; Bozzola, M.; Milani, P.; Nuvolone, M.; Lavatelli, F.; Ferraro, G.; Bosoni, T.; Pirolini, L.; Albertini, R.; Palladini, G. | |
A complicated evaluation of the response to the therapy in a patient with light chain deposition disease | 1-gen-2020 | Ripepi, J.; Basset, M.; Milani, P.; Nuvolone, M.; Foli, A.; Bozzola, M.; Bosoni, T.; Albertini, R.; Palladini, G. | |
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis | 1-gen-2015 | Palladini, Giovanni; Sachchithanantham, S.; Milani, Paolo; Gillmore, J.; Foli, Andrea; Lachmann, H.; Basset, Marco; Hawkins, P.; Merlini, Giampaolo; Wechalekar, A. D. | |
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. | 1-gen-2013 | Wechalekar, A. D.; Schonland, S. O.; Kastritis, E.; Gillmore, J. D.; Dimopoulos, M. A.; Lane, T.; Foli, A.; Foard, D.; Milani, P.; Rannigan, L.; Hegenbart, U.; Hawkins, P. N.; Merlini, Giampaolo; Palladini, Giovanni | |
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. | 1-gen-2001 | Palladini, Giovanni; Anesi, E; Perfetti, V; Obici, L; Invernizzi, Rosangela; Balduini, Carlo; Ascari, Edoardo; Merlini, Giampaolo | |
A modified high-dose dexamethasone regimen for primary systemic amyloidosis | 1-gen-1999 | Merlini, Giampaolo; Anesi, E; Palladini, Giovanni; Perfetti, V; Obici, L; Invernizzi, Rosangela; Balduini, Carlo; Ascari, Edoardo; Cazzola, Mario | |
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin in primary amyloidosis (AL) | 1-gen-2002 | Gertz, Ma; Lacy, Mq; Dispenzieri, A; Cheson, B; Barlogie, B; Kyle, Ra; Palladini, Giovanni; Geyer, S; Merlini, Giampaolo | |
A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis | 1-gen-2022 | Palladini, G.; Celant, S.; Milani, P.; Summa, V.; Affronti, G.; Olimpieri, P. P.; Petraglia, S.; Foli, A.; Nuvolone, M.; Merlini, G.; Russo, P. | |
A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options | 1-gen-2019 | Moutafi, M.; Ziogas, D. C.; Michopoulos, S.; Bagratuni, T.; Vasileiou, V.; Verga, L.; Merlini, G.; Palladini, G.; Matsouka, C.; Dimopoulos, M. A.; Kastritis, E. | |
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy | 1-gen-2005 | Obici, L.; Demarchi, A.; de Rosa, G.; Bellotti, Vittorio; Marciano, S.; Donadei, S.; Arbustini, E.; Palladini, Giovanni; Diegoli, M.; Genovese, E.; Ferrari, G.; Coverlizza, S.; Merlini, Giampaolo | |
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. | 1-gen-2005 | Obici, L; Demarchi, A; DE ROSA, G; Bellotti, Vittorio; Marciano, S; Donadei, S; Arbustini, Eloisa; Palladini, Giovanni; Diegoli, M; Genovese, E; Ferrari, G; Coverlizza, S; Merlini, Giampaolo | |
A novel approach for the purification and proteomic analysis of pathogenic immunglobulin free light chains from serum | 1-gen-2011 | Lavatelli, Francesca; Brambilla, Francesca; Valentini, Veronica; Rognoni, Paola; Casarini, Simona; Di Silvestre, Dario; Perfetti, Vittorio; Palladini, Giovanni; Sarais, Gabriele; Mauri, Pierluigi; Merlini, Giampaolo | |
A patient with AL amyloidosis with negative free light chain results | 1-gen-2016 | Milani, Paolo; Valentini, Veronica; Ferraro, Giovanni; Basset, Marco; Russo, Francesca; Foli, Andrea; Palladini, Giovanni; Merlini, Giampaolo | |
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory light-chain (AL) amyloidosis | 1-gen-2017 | Sanchorawala, V; Palladini, Giovanni; Kukreti, V; Zonder, Ja; Cohen, Ad; Seldin, Dc; Dispenzieri, A; Jaccard, A; Schönland, So; Berg, D; Yang, H; Gupta, N; Hui, Am; Comenzo, Rl; Merlini, Giampaolo | |
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis | 1-gen-2017 | Palladini, G.; Milani, P.; Foli, A.; Basset, M.; Russo, F.; Perlini, S.; Merlini, G. | |
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis | 1-gen-2017 | Palladini, Giovanni; Milani, Paolo; Foli, Andrea; Basset, Marco; Russo, Francesca; Perlini, Stefano; Merlini, Giampaolo | |
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis | 1-gen-2013 | Palladini, Giovanni; Russo, PAOLA ROSA NICE MARIA; Milani, P.; Foli, A.; Lavatelli, Francesca; Nuvolone, MARIO ULISSE; Perlini, Stefano; Merlini, Giampaolo | |
A powerful oral triplet for AL amyloidosis | 1-gen-2020 | Palladini, G.; Milani, P.; Merlini, G. |